A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type

NCT03548584 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

345

Enrollment

INDUSTRY

Sponsor class

Conditions

Agitation Associated With Alzheimer's Dementia
Alzheimer Dementia

Interventions

DRUG: Brexpiprazole
OTHER: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators

[object Object]